Stay updated on Nivolumab for Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Cervical Cancer Clinical Trial page.

Latest updates to the Nivolumab for Cervical Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study details with an access-denied screen. This appears to be a permissions/configuration issue rather than an update to the study content.SummaryDifference16%

- Check20 days agoChange DetectedNew September 2026 update dates (2026-09-08, 2026-09-04, 2026-09) were added to the page's history, while older dates (2026-08-28, 2026-08-27, 2026-03) were removed, reflecting maintenance of the study record.SummaryDifference0.1%

- Check34 days agoChange DetectedThe study location list was updated to add Kaiser Permanente-Rio San Diego and remove Kaiser Permanente-San Diego Mission. This reflects a change in site availability and the associated revision to v3.6.6.SummaryDifference0.1%

- Check56 days agoChange DetectedThe study's listed locations were updated to 331, and the BJC Outpatient Center at Sunset Hills was removed from the list. The study record revision version advanced from v3.6.4 to v3.6.5.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page now shows Revision: v3.6.4 instead of Revision: v3.6.3, signaling a minor backend or formatting update to the study page rather than changes to the study data.SummaryDifference0.0%

- Check92 days agoChange DetectedParticipating sites were updated: Bardstown, East Lexington, and Lahey Clinic were added. At the same time, Flaget Memorial Hospital, Saint Joseph Hospital East, and Lahey Hospital and Medical Center were removed, and the document revision was updated to v3.6.3.SummaryDifference0.1%

Stay in the know with updates to Nivolumab for Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Cervical Cancer Clinical Trial page.